UK MHRA's proposed scheme on earlier access to medicines halted
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency has decided not to go ahead with its much-publicised scheme to allow earlier patient access to promising new drugs on the National Health Service1. The proposed scheme was approved by a key ministerial panel in December 2009 and was intended to provide earlier access, at the end of Phase II clinical trials in some cases, to investigational medicines2.
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.